Dermatology · Los Angeles, CA
NPI
1306200902
Since 2016
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4733 W Sunset Blvd Fl 3
Los Angeles, CA, 90027
Phone (323) 783-4516
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$95K
681 prescriptions
Company payments, 2023
$154
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Megan S Inkeles prescribed most often to Medicare patients was Clobetasol Propionate, with 90 prescriptions and refills. In total Megan S Inkeles wrote 681 Medicare prescriptions that cost $95K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 90 | 90 | 49 | $2,102 |
| Triamcinolone Acetonide Generic | 51 | 59 | 38 | $1,803 |
| Fluorouracil Generic | 48 | 48 | 40 | $1,752 |
| Ketoconazole Generic | 39 | 41 | Under 11 | $721 |
| Hydrocortisone Generic | 26 | 31 | 18 | $527 |
| Mycophenolate Mofetil Generic | 26 | 35 | Under 11 | $1,965 |
| Hydroxychloroquine Sulfate Generic | 25 | 69 | Under 11 | $816 |
| Tacrolimus Generic | 25 | 32 | 16 | $2,717 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 25 | Under 11 | $179 |
| Mupirocin Generic | 23 | 23 | Under 11 | $229 |
| Doxycycline Monohydrate Generic | 21 | 32 | 12 | $721 |
| Prednisone Generic | 20 | 35 | Under 11 | $244 |
| Methotrexate Methotrexate Sodium | 18 | 28 | Under 11 | $152 |
| Acyclovir Generic | 16 | 16 | Under 11 | $12K |
| Bexarotene Generic | 14 | 14 | Under 11 | $11K |
Brand drugs: 47 claims; generic drugs: 634 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Megan S Inkeles $154 ($154 in general payments such as food, travel and fees) from 2 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.